Risk prediction models developed in other countries require validation and recalibration before use in a new country setting to ensure accurate risk-adjusted outcomes.
Answers are grounded in this paper and cite their sources.
Clinicians should validate and recalibrate imported models locally before use; supports need for country-specific validation studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Harrison et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: